Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143668 |
| CAS No | NA |
| Mol.F. | C19H20N4O2 |
| Mol.Wt. | 336.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143669 |
| CAS No | NA |
| Mol.F. | C28H36N4O6 |
| Mol.Wt. | 524.62 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143670 |
| CAS No | NA |
| Mol.F. | C29H37N3O7 |
| Mol.Wt. | 539.63 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143671 |
| CAS No | NA |
| Mol.F. | C11H21N3O5 |
| Mol.Wt. | 275.30 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143672 |
| CAS No | NA |
| Mol.F. | C25H30N4O7 |
| Mol.Wt. | 498.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143673 |
| CAS No | NA |
| Mol.F. | C20H22N4O5 |
| Mol.Wt. | 398.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143674 |
| CAS No | NA |
| Mol.F. | C20H21N5O6 |
| Mol.Wt. | 427.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143675 |
| CAS No | NA |
| Mol.F. | C14H10D8N6O3 |
| Mol.Wt. | 326.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143676 |
| CAS No | NA |
| Mol.F. | C9H7D8N3O3 |
| Mol.Wt. | 221.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143677 |
| CAS No | 20002-25-9 |
| Mol.F. | C11H16N2O |
| Mol.Wt. | 192.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143678 |
| CAS No | NA |
| Mol.F. | C13H23N5O4S |
| Mol.Wt. | 345.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143679 |
| CAS No | NA |
| Mol.F. | C13H23N5O4S |
| Mol.Wt. | 345.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143680 |
| CAS No | NA |
| Mol.F. | C19H30N8O5S2 |
| Mol.Wt. | 514.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143681 |
| CAS No | NA |
| Mol.F. | C17H25N5O7S |
| Mol.Wt. | 443.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143682 |
| CAS No | NA |
| Mol.F. | C17H8D8N4OS |
| Mol.Wt. | 332.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143683 |
| CAS No | NA |
| Mol.F. | C21H27N3O6 |
| Mol.Wt. | 417.5 g/mole |
| INV STATUS | UNDER SYNTHESIS |